PubRank

S T DeKosky

Author PubWeight™ 190.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 2006 12.10
2 Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001 7.68
3 Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001 7.51
4 Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci 2000 6.54
5 Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA 1997 5.09
6 Prevalence of Alzheimer's disease and other dementias in rural India: the Indo-US study. Neurology 1998 3.82
7 Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001 3.74
8 Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study. Arch Gen Psychiatry 2001 3.32
9 Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 2007 3.26
10 Incidence of Alzheimer's disease in a rural community in India: the Indo-US study. Neurology 2001 2.99
11 Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology 2000 2.79
12 Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology 1998 2.70
13 Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades: I. Neurology 2000 2.64
14 Treatment of traumatic brain injury with moderate hypothermia. N Engl J Med 1997 2.62
15 Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol 2001 2.51
16 Quantitative assessment of cortical synaptic density in Alzheimer's disease. Neurobiol Aging 1990 2.14
17 The temporal relationship between depressive symptoms and dementia: a community-based prospective study. Arch Gen Psychiatry 1999 2.07
18 Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study. Arch Neurol 2000 2.04
19 Ten-year incidence of dementia in a rural elderly US community population: the MoVIES Project. Neurology 2000 2.03
20 Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale. J Am Geriatr Soc 1998 1.88
21 Neuropsychological characteristics of mild cognitive impairment subgroups. J Neurol Neurosurg Psychiatry 2005 1.83
22 Interleukin-8 is increased in cerebrospinal fluid of children with severe head injury. Crit Care Med 2000 1.82
23 Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study. Neurology 2008 1.71
24 Determinants of vascular dementia in the Cardiovascular Health Cognition Study. Neurology 2005 1.70
25 Linkage analysis of Alzheimer disease with psychosis. Neurology 2002 1.58
26 Research evaluation and diagnosis of possible Alzheimer's disease over the last two decades: II. Neurology 2000 1.57
27 Compensatory reallocation of brain resources supporting verbal episodic memory in Alzheimer's disease. Neurology 1996 1.55
28 Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol Psychiatry 2009 1.51
29 EEG spectral abnormalities and psychosis as predictors of cognitive and functional decline in probable Alzheimer's disease. Neurology 1997 1.48
30 Traumatic brain injury-induced excitotoxicity assessed in a controlled cortical impact model. J Neurochem 1993 1.46
31 Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease. Arch Neurol 1999 1.45
32 Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias. Neurology 1999 1.42
33 Reliability of NINDS-AIREN clinical criteria for the diagnosis of vascular dementia. Neurology 1994 1.39
34 Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease. J Neurol Neurosurg Psychiatry 2002 1.37
35 Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children. J Neurotrauma 1997 1.36
36 One-year study of spatial memory performance, brain morphology, and cholinergic markers after moderate controlled cortical impact in rats. J Neurotrauma 1999 1.33
37 Inducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and mice. J Clin Invest 1999 1.21
38 Extrapyramidal signs in patients with probable Alzheimer disease. Arch Neurol 1997 1.20
39 Early neuropathologic effects of mild or moderate hypoxemia after controlled cortical impact injury in rats. J Neurotrauma 1997 1.18
40 Classification of vascular dementia in the Cardiovascular Health Study Cognition Study. Neurology 2005 1.17
41 Apoptotic interactions of cytochrome c: redox flirting with anionic phospholipids within and outside of mitochondria. Biochim Biophys Acta 2006 1.15
42 Increased familial risk of the psychotic phenotype of Alzheimer disease. Neurology 2002 1.15
43 Awareness of cognitive deficits and anosognosia in probable Alzheimer's disease. Eur Neurol 1994 1.14
44 Small head size is related to low Mini-Mental State Examination scores in a community sample of nondemented older adults. Neurology 1999 1.14
45 Volumetric atrophy of the amygdala in Alzheimer's disease: quantitative serial reconstruction. Neurology 1991 1.13
46 Genome-wide association study of Alzheimer's disease with psychotic symptoms. Mol Psychiatry 2011 1.11
47 Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures. Mol Psychiatry 2006 1.09
48 Gender-specific aging effects on the serotonin 1A receptor. Brain Res 2001 1.08
49 Amygdala cell loss and atrophy in Alzheimer's disease. Ann Neurol 1992 1.07
50 Monoamine neurons in aging and Alzheimer's disease. J Neural Transm Gen Sect 1993 1.06
51 Association between dementia and elevated TSH: a community-based study. Biol Psychiatry 1996 1.06
52 Genome-wide association analysis of age-at-onset in Alzheimer's disease. Mol Psychiatry 2011 1.05
53 Mild posttraumatic hypothermia reduces mortality after severe controlled cortical impact in rats. J Cereb Blood Flow Metab 1996 1.03
54 Hypothermia attenuates the normal increase in interleukin 1 beta RNA and nerve growth factor following traumatic brain injury in the rat. J Neurotrauma 1995 1.03
55 APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism. Nat Genet 1995 1.03
56 Precuneus amyloid burden is associated with reduced cholinergic activity in Alzheimer disease. Neurology 2011 1.00
57 Analysis of genetic polymorphisms in the transforming growth factor-beta1 gene and the risk of Alzheimer's disease. Hum Genet 2000 0.99
58 Fetal grafting for Parkinson's disease: expression of immune markers in two patients with functional fetal nigral implants. Cell Transplant 1997 0.99
59 Neurologic factors associated with cognitive impairment in a rural elderly population in India: the Indo-US Cross-National Dementia Epidemiology Study. J Geriatr Psychiatry Neurol 1998 0.98
60 Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depression. Am J Psychiatry 2001 0.97
61 Hypothyroidism and cognition: preliminary evidence for a specific defect in memory. Thyroid 2001 0.96
62 Bleomycin hydrolase is associated with risk of sporadic Alzheimer's disease. Nat Genet 1998 0.96
63 Psychotic symptoms in Alzheimer's disease are not associated with more severe neuropathologic features. Int Psychogeriatr 2000 0.95
64 Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity. J Virol 1999 0.95
65 Expression of differential immune factors in temporal cortex and cerebellum: the role of alpha-1-antichymotrypsin, apolipoprotein E, and reactive glia in the progression of Alzheimer's disease. J Comp Neurol 1998 0.94
66 Severity of cognitive impairment and the clinical diagnosis of AD with Lewy bodies. Neurology 2000 0.94
67 Serum anticholinergic activity, white matter hyperintensities, and cognitive performance. Neurology 2005 0.94
68 The apolipoprotein E epsilon 4 allele is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's disease. Neurology 1997 0.94
69 Predictors of progression in patients with AD and Lewy bodies. Neurology 2000 0.94
70 Phenotypic variability in three families with valosin-containing protein mutation. Eur J Neurol 2012 0.94
71 Computed tomography--but not magnetic resonance imaging--identified periventricular white-matter lesions predict symptomatic cerebrovascular disease in probable Alzheimer's disease. Arch Neurol 1995 0.94
72 Dopamine receptor genetic variation, psychosis, and aggression in Alzheimer disease. Arch Neurol 1998 0.94
73 Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease. Mol Psychiatry 2005 0.94
74 Alterations of striatal dopamine receptor binding in Alzheimer disease are associated with Lewy body pathology and antemortem psychosis. Arch Neurol 2001 0.93
75 Functional connectivity in auditory-verbal short-term memory in Alzheimer's disease. Neuroimage 1996 0.92
76 Astrocytes are the major source of nerve growth factor upregulation following traumatic brain injury in the rat. Exp Neurol 1998 0.92
77 Reduced binding of [18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction. Brain Res 1998 0.92
78 The 5-HTTPR polymorphism confers liability to a combined phenotype of psychotic and aggressive behavior in Alzheimer disease. Int Psychogeriatr 2001 0.91
79 A novel mutation in the apolipoprotein E gene (APOE*4 Pittsburgh) is associated with the risk of late-onset Alzheimer's disease. Neurosci Lett 1999 0.91
80 Assessment of cerebral blood flow and CO2 reactivity after controlled cortical impact by perfusion magnetic resonance imaging using arterial spin-labeling in rats. J Cereb Blood Flow Metab 1997 0.91
81 PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders. Am J Psychiatry 1999 0.91
82 Recognition and discrimination of emotional faces and pictures. Brain Lang 1980 0.90
83 Quinolinic acid is increased in CSF and associated with mortality after traumatic brain injury in humans. J Cereb Blood Flow Metab 1998 0.90
84 The antioxidant enzymes glutathione peroxidase and catalase increase following traumatic brain injury in the rat. Exp Neurol 1997 0.90
85 Dementia with Lewy bodies: response of delirium-like features to donepezil. Neurology 1998 0.89
86 Association of 3'-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer's disease. J Med Genet 2003 0.89
87 Perinatal glucocorticoids disrupt learning: a sexually dimorphic response. Physiol Behav 1986 0.88
88 Genetic association studies between Alzheimer's disease and two polymorphisms in the low density lipoprotein receptor-related protein gene. Neurosci Lett 1998 0.87
89 Regional distribution of neural cell adhesion molecule (N-CAM) and L1 in human and rodent hippocampus. J Comp Neurol 1993 0.87
90 Increased transmitter amino acid concentration in human ventricular CSF after brain trauma. Neuroreport 1994 0.87
91 Gonadal steroids influence axon sprouting in the hippocampal dentate gyrus: a sexually dimorphic response. Exp Neurol 1986 0.87
92 Antibodies against Mac-1 attenuate neutrophil accumulation after traumatic brain injury in rats. J Neurotrauma 1996 0.87
93 Quantitation of synaptic density in the septal nuclei of young and aged Fischer 344 rats. Neurobiol Aging 1991 0.86
94 The psychotic phenomenon in probable Alzheimer's disease: a positron emission tomography study. J Neuropsychiatry Clin Neurosci 2001 0.86
95 The effect of brain temperature on acute inflammation after traumatic brain injury in rats. J Neurotrauma 1997 0.86
96 Soluble adhesion molecules in CSF are increased in children with severe head injury. J Neurotrauma 1998 0.86
97 Dementia accompanying motor neuron disease. Dementia 1994 0.85
98 Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer's disease. Neurosci Lett 2000 0.85
99 Laminar organization of cholinergic circuits in human frontal cortex in Alzheimer's disease and aging. Neurology 1985 0.84
100 The relation of White Matter Hyperintensities to implicit learning in healthy older adults. Int J Geriatr Psychiatry 2002 0.84
101 The 5-HTTPR*S/*L polymorphism and aggressive behavior in Alzheimer disease. Arch Neurol 2001 0.83
102 [Neuropathology of Alzheimer's disease and mild cognitive impairment]. Rev Neurol 2003 0.83
103 Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease. Neurology 2005 0.83
104 Elevated corticosterone levels. A possible cause of reduced axon sprouting in aged animals. Neuroendocrinology 1984 0.83
105 Comparison of the interleukin-6 and interleukin-10 response in children after severe traumatic brain injury or septic shock. Acta Neurochir Suppl 1997 0.83
106 Psychiatric symptoms associated with cortical-subcortical dysfunction in Alzheimer's disease. J Neuropsychiatry Clin Neurosci 2001 0.83
107 Resuscitation from severe brain trauma. Crit Care Med 1996 0.82
108 Morphologic and behavioral effects of perinatal glucocorticoid administration. Physiol Behav 1982 0.82
109 Cognitive stability over 2 years in a rural elderly population: the MoVIES project. Neuroepidemiology 1996 0.82
110 Right prosubiculum amyloid plaque density correlates with anosognosia in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2004 0.82
111 Genetic association studies of interleukin-1 (IL-1A and IL-1B) and interleukin-1 receptor antagonist genes and the risk of Alzheimer's disease. Ann Neurol 2000 0.82
112 Replication study of genome-wide associated SNPs with late-onset Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 2011 0.81
113 Epidermal growth factor receptor expression in demented elderly: localization to vascular endothelial cells of brain, pituitary and skin. Brain Res 1993 0.81
114 Up-regulation of type 2 iodothyronine deiodinase mRNA in reactive astrocytes following traumatic brain injury in the rat. J Neurochem 1998 0.80
115 Steroid suppression of axon sprouting in the hippocampal dentate gyrus of the adult rat: dose-response relationship. Exp Neurol 1983 0.80
116 Genetic association of two chromosome 14 genes (presenilin 1 and alpha 1-antichymotrypsin) with Alzheimer's disease. Ann Neurol 1998 0.80
117 Chronic effects of traumatic brain injury on hippocampal vesicular acetylcholine transporter and M2 muscarinic receptor protein in rats. Exp Neurol 1998 0.80
118 Alzheimer's disease. Aminergic-cholinergic alterations in hypothalamus. Arch Neurol 1988 0.80
119 Alternate strategies in lesion-induced reactive synaptogenesis: differential expression of L1 in two populations of sprouting axons. Exp Neurol 1995 0.80
120 Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease. Ann Neurol 1992 0.80
121 Promoting interactions with basic scientists and clinicians: the NIA Alzheimer's Disease Data Coordinating Center. Stat Med 2000 0.79
122 Embryonic neural cell adhesion molecule (N-CAM) is elevated in the denervated rat dentate gyrus. J Neurosci 1994 0.79
123 Strain comparison of synaptic density in hippocampal CA1 of aged rats. Neurobiol Aging 1985 0.79
124 Evidence for the association of the S100beta gene with low cognitive performance and dementia in the elderly. Mol Psychiatry 2007 0.79
125 Augmented neuronal death in CA3 hippocampus following hyperventilation early after controlled cortical impact. J Neurosurg 1998 0.79
126 Apolipoprotein E polymorphism in Alzheimer's disease: a comparative study of two research populations from Spain and the United States. Eur Neurol 1998 0.78
127 Effects of a history of heavy alcohol consumption on Alzheimer's disease. Br J Psychiatry 1993 0.78
128 Neurotrophic effects of steroids on lesion-induced growth in the hippocampus. II. Hormone replacement. Exp Neurol 1992 0.78
129 Reactive synaptogenesis in hippocampal area CA1 of aged and young adult rats. J Comp Neurol 1986 0.77
130 Genetic polymorphism in the cathepsin G gene and the risk of Alzheimer's disease. Neurosci Lett 2001 0.77
131 Psychiatric correlates of MR deep white matter lesions in probable Alzheimer's disease. J Neuropsychiatry Clin Neurosci 1997 0.77
132 Symptoms of depression in Alzheimer's disease, frontal lobe-type dementia, and subcortical dementia. Ann N Y Acad Sci 1995 0.77
133 Gender-specific nonrandom association between the alpha 1-antichymotrypsin and apolipoprotein E polymorphisms in the general population and its implication for the risk of Alzheimer's disease. Genet Epidemiol 1997 0.76
134 Perfusion MRI assessment of cerebral blood flow and CO2 reactivity after controlled cortical impact in rats. Adv Exp Med Biol 1997 0.76
135 Lack of association between alpha2-macroglobulin polymorphisms and Alzheimer's disease. Hum Genet 2001 0.75
136 Cognitive mental status examinations. Clin Geriatr Med 1989 0.75
137 Registries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task Force. J Prev Alzheimers Dis 2016 0.75
138 Dementia associated with dorsal midbrain lesion. J Int Neuropsychol Soc 1996 0.75
139 Strain differences and laminar localization of structural neurochemical changes in aging rat. Neurobiol Aging 1985 0.75
140 Genetic polymorphism in the persyn (gamma-synuclein) gene and the risk of Alzheimer's disease. Neurosci Lett 1999 0.75
141 Electroencephalographic correlates of periventricular white matter lesions in probable Alzheimer's disease. Dementia 1996 0.75
142 Stability of sialogangliosides in kindled hippocampus. Exp Neurol 1986 0.75
143 Aging, senile dementia, and the intralaminar microchemistry of cerebral cortex. Neurology 1982 0.75
144 Rapid expression and transport of embryonic N-CAM in dentate gyrus following entorhinal cortex lesion: ultrastructural analysis. J Comp Neurol 1994 0.75
145 Altered striatal dopaminergic metabolism 36 hours after unilateral trauma to the human mesencephalon. Neurology 1987 0.75
146 The establishment of a brain bank for the study of late-life depression: a feasibility study of factors facilitating consent. CNS Spectr 2002 0.75
147 Neurotrophic effects of steroids on lesion-induced growth in the hippocampus. I. The asteroidal condition. Brain Res 1988 0.75
148 Hydrocortisone differentially alters lesion-induced axon sprouting in male and female rats. Exp Neurol 1988 0.75
149 Perinatal glucocorticoids alter dentate gyrus electrophysiology. Brain Res Bull 1985 0.75
150 Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease. Ann Neurol 1995 0.75
151 Dementia among elderly apolipoprotein E type 4/4 homozygotes: a prospective study. Genet Epidemiol 1995 0.75
152 Iodine-123 HIPDM brain imaging findings in subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). J Nucl Med 1987 0.75
153 Epidermal growth factor receptor expression in skin does not predict dementia in the elderly. Dement Geriatr Cogn Disord 1998 0.75